These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma. Goldkuhle M, Kreuzberger N, von Tresckow B, Eichenauer DA, Specht L, Monsef I, Skoetz N. Cochrane Database Syst Rev; 2024 Dec 02; 12(12):CD007110. PubMed ID: 39620432 [Abstract] [Full Text] [Related]
6. Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment. Wang K, Xu M, Wang Y, Xu C, Hao Y, Song Z. Clin Transl Oncol; 2024 Oct 02; 26(10):2479-2487. PubMed ID: 38625494 [Abstract] [Full Text] [Related]
10. DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer. Bestvina CM, Hara JHL, Karrison T, Bowar B, Chin J, Garassino MC, Pitroda SP, Thawani R, Vokes EE, Gan G, Zhang J, Baschnagel AM, Campbell TC, Chmura S, Juloori A. Clin Lung Cancer; 2024 Dec 02; 25(8):e448-e452. PubMed ID: 39242330 [Abstract] [Full Text] [Related]
11. Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials. Wang Q, Yu J, Sun X, Li J, Cao S, Han Y, Wang H, Yang Z, Li J, Hu C, Zhang Y, Jin L. Crit Rev Oncol Hematol; 2024 Dec 02; 204():104522. PubMed ID: 39332750 [Abstract] [Full Text] [Related]
15. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database. Cabart M, Mourey L, Pasquier D, Schneider S, Léna H, Girard N, Chouaid C, Schott R, Hiret S, Debieuvre D, Quantin X, Madroszyk A, Dubray-Longeras P, Pichon E, Baranzelli A, Justeau G, Pérol M, Bosquet L, Cabarrou B. J Geriatr Oncol; 2024 Sep 02; 15(7):101819. PubMed ID: 39068144 [Abstract] [Full Text] [Related]
17. First-line chemoimmunotherapy for patients with small-cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis. Li Y, Jiang Y, Pan L, Yao J, Liang S, Du Y, Wang D, Liu H, Zhang F, Wang Q, Lv T, Zhan P. Thorac Cancer; 2024 Dec 02; 15(34):2437-2448. PubMed ID: 39435523 [Abstract] [Full Text] [Related]